AzTrials
AzTrials

Post-Traumatic Stress DisorderTRAUMAFFECTNCT05020197

Study of the Association Between the Type of Attachment and the Risk of Post-Traumatic Stress Disorder

An observational study of Post-Traumatic Stress Disorder, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Attachment theory models the emotional bonding that is activated in situations of danger, via mental representations of self and others. Four types of attachment (TA) exist in adults: 3 insecure (Preoccupied, Detached, Fearful) and 1 secure. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-Traumatic Stress Disorder
What is being tested?
self-questionnaires on attachment and PTSD
How many people
268 participants
Where
1 siteFrance
Study dates
23 Mar 2022to 7 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Having experienced a Potentially Traumatic Event within 3 days and according to DSM5 criterion A: Exposure to actual or potential death, serious injury, or sexual violence in one (or more) of the following ways: Directly experiencing the traumatic event, witnessing the event in person by others, learning that the traumatic event (violent or accidental) was experienced by a close family member or friend, experiencing repeated or extreme exposure to the harrowing details of the traumatic event (e.g., first responders or police officers) (exposure through electronic media, television, films, or photographs, if the exposure is work-related)

Who may be able to join

  • Major patient
  • Having experienced a Potentially Traumatic Event within 3 days and according to DSM5 criterion A: Exposure to actual or potential death, serious injury, or sexual violence in one (or more) of the following ways: Directly experiencing the traumatic event, witnessing the event in person by others, learning that the traumatic event (violent or accidental) was experienced by a close family member or friend, experiencing repeated or extreme exposure to the harrowing details of the traumatic event (e.g., first responders or police officers) (exposure through electronic media, television, films, or photographs, if the exposure is work-related)
  • Good understanding of oral and written French
  • Having given written consent
  • Patient affiliated to a social security scheme

Who cannot join

  • Psychiatric pathology with current clinical instability (agitation, maladaptive consciousness...) or patient unable to understand questionnaires
  • Vulnerable adult (curatorship, guardianship)
  • Non French resident

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de médecine et santé au travail des HCL

    Lyon, 69003

Other trials in France

About this study

Official title: Study of the Association Between the Type of Attachment and the Risk of Post-Traumatic Stress Disorder: A Prospective Cohort Study in the Forensic Medicine Department of the Hospices Civils de Lyon

Attachment theory models the emotional bonding that is activated in situations of danger, via mental representations of self and others. Four types of attachment (TA) exist in adults: 3 insecure (Preoccupied, Detached, Fearful) and 1 secure. Attachment type is a major factor in the development of Post-Traumatic Stress Disorder (PTSD), a frequent and disabling mental disorder that occurs after a traumatic event. A meta-analysis based on Anglo-Saxon studies including various populations (general, military or clinical) (n=9268 patients) suggested an association between Fearful BP and high level of PTSD symptoms (r=0.44). Nevertheless, these results did not allow the identification of variations related to the individual risk factors (RDFs) of the subject and his environment, especially in the French socio-cultural context. The investigators propose to study the association between LDs and the risk of PTSD in the days following exposure, their mutual influence in the months following, and their associated factors. Thus, a prospective cohort study among French adult victims of a traumatic event could objectify the link between BP - as close as possible to the event - and the risk of PTSD.

Being tested
self-questionnaires on attachment and PTSD
Keywords
Attachment, PTSD, risk factor
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • self-questionnaires on attachment and PTSDDiagnostic test

    The questionnaires (attachement type, PTSD symptoms) are administered face to face at the inclusion visit (at D0-D3). Validated self-questionnaires in French will be sent to the patients, either electronically or by post, according to their choice at D30 and D90. To describe the characteristics of the subjects, socio-demographic data, lifestyle, and medical history will be collected. The questionnaires will be administered three times to study the evolution of the parameters over time.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire

    Type of attachment Disorder will be measured at inclusion by the ECR-R attachment questionnaire. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree.

    Measured: Day 30

  2. Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    Risk of developing Post Traumatic Stress Disorder. Items are rated on a 5 point scale. The maximum score is 80.

    Measured: Day 30

  3. Correlation between Questionnaire PCL-5 AND ECR-R attachment questionnaire

    Correlation of outcome 1 and outcome 2

    Measured: Day 30

Secondary outcomes (12)
  1. Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    Risk of Post-Traumatic Stress Disorder at 90 days. Items are rated on a 5 point scale. The maximum score is 80.

    Measured: Day 90

  2. Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    Type of attachment. Items are rated on a 5 point scale. The maximum score is 80.

    Measured: Day 90

  3. Correlation between PCL-5 questionnaire.And PCL-5 questionnaire.at D90

    Correlation between the type of attachment and the risk of Post-Traumatic Stress Disorder

    Measured: Day 90

  4. Relationship Scales Questionnaire (RSQ)

    30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized)

    Measured: Day 3

  5. Relationship Scales Questionnaire (RSQ)

    30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized)

    Measured: Day 30

  6. Relationship Scales Questionnaire (RSQ)

    Measure of Psychometric performance; 30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized)

    Measured: Day 90

  7. Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire

    Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree

    Measured: Day 3

  8. Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire

    Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree

    Measured: Day 30

  9. Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire

    Attachment Type. Each item is rated on a 7-point scale where 1 = strongly disagree and 7 = strongly agree

    Measured: Day 90

  10. Questionnaire Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)

    Risk of Post Traumatic Stress Disorder (D90). Items are rated on a 5 point scale. The maximum score is 80.

    Measured: Day 90

  11. Impact of Event Scale Revised

    The IES-R consists of a list of 22 symptoms of PTSD. The person indicates the intensity with which each symptom has manifested itself over the past 7 days, by self-reporting their response on a 5-point Lykert-type scale, ranging from 0 ("Not at all") to 4 ( "Extremely"). The total IES-R score is calculated by adding the values obtained for the 22 items (scores 0-88).

    Measured: Day 3

  12. Relationship Scales Questionnaire (RSQ)

    30-item self-questionnaire that categorizes participants into four categories of attachment (secure or autonomous, avoiding or detached, preoccupied or ambivalent, fearful or disorganized)

    Measured: Day 90

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Aug 2021
  2. Study start23 Mar 2022
  3. Primary completion7 Nov 2024
  4. Study completion7 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
268 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05020197
Sponsor's protocol ID
69HCL20_0814
Acronym
TRAUMAFFECT
Status last verified
Nov 2024
First submitted
19 Jul 2021
Last updated
25 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post-Traumatic Stress Disorder, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Experiences in Close Relationships-Revised (ECR-R) attachment questionnaire (time frame: Day 30). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in